Free shipping on all orders over $ 500

Rocaglamide

Cat. No. M14607
Rocaglamide Structure
Synonym:

Roc-A

Size Price Availability Quantity
5mg USD 540  USD540 In stock
10mg USD 920  USD920 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Rocaglamide (Roc-A) is isolated from the genus Aglaia and can be used for coughs, injuries, asthma and inflammatory skin diseases. Rocaglamide is a potent inhibitor of NF-κB activation in T-cells. Rocaglamide is a potent and selective heat shock factor 1 (HSF1) activation inhibitor with an IC50 of ~50 nM. Rocaglamide inhibits the function of the translation initiation factor eIF4A. Rocaglamide also has anticancer properties in leukemia.

Chemical Information
Molecular Weight 505.56
CAS Number 84573-16-0
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Gran Schulz, et al. Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds

[2] Chaojun Yan, et al. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis

[3] Shintaro Iwasaki, et al. The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA

[4] Li Pan, et al. Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species

[5] Xiao-Hua Cai, et al. Progress in the total synthesis of rocaglamide

Related NF-κB Products
Narlumosbart

Narlumosbart is a human IgG4ҡ monoclonal antibody (mAb) that targets Receptor Activating Factor for Nuclear Factor κB Ligand (RANKL) and can be used in studies related to Giant Cell Tumor of Bone (GCTB).

Ac2-26

Ac2-26, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury.

Mitogen-activated protein kinase 1

Mitogen-activated protein kinase 1 (MAPK1) can activate the downstream p38/NF-κB pathway.

IKKγ NBD Inhibitory Peptide

IKKγ NBD Inhibitory Peptide is a highly specific inhibitor NF-κB inhibitor.

Tripeptide-41

Tripeptide-41(CG-Lipoxyn)isa bioactive peptide withreduce fat accumulationeffect and has been reported used as a cosmetic ingredient.

  Catalog
Abmole Inhibitor Catalog




Keywords: Rocaglamide, Roc-A supplier, NF-κB, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.